T-Cell Therapy Market, By Therapy (CAR T-Cell, Tumor Infiltrating Lymphocytes), By Indication (Hematologic Malignancies, Solid Tumors), By Region (North America, Europe, Asia Pacific, Middle East & Africa, and South America) – Market Size & Forecasting To 2028

The T-Cell Therapy Market report points out national and global business prospects and competitive conditions for T-cell therapy. Market size estimation and forecasts were given based on a detailed research methodology tailored to the conditions of the demand for T-cell therapy. The T-cell therapy market has been segmented by therapy (car t-cell, tumor infiltrating lymphocytes), by indication (hematologic malignancies, solid tumors). Historical background for the demand of T-cell therapy has been studied according to organic and inorganic innovations in order to provide accurate estimates of the market size. Primary factors influencing the growth of the demand T-cell therapy have also been established with potential gravity. Major regions covered in the study include North America, Europe, Asia Pacific, Middle East & Africa, and South America.

Market Segmentation:

By Therapy:

  • CAR T-Cell
  • Tumor Infiltrating Lymphocytes

By Indication:

  • Hematologic Malignancies
  • Solid Tumors

By Region:

North America T-cell therapy Market

  • North America, by Country
    • US
    • Canada
    • Mexico
  • North America, by Therapy,
  • North America, by Indication

Europe T-cell therapy Market

  • Europe, by Country
    • Germany
    • Russia
    • UK
    • France
    • Italy
    • Spain
    • The Netherlands
    • Rest of Europe 
  • Europe, by Therapy,
  • Europe, by Indication

Asia Pacific T-cell therapy Market

  • Asia Pacific, by Country
    • China
    • India
    • Japan
    • South Korea
    • Australia
    • Indonesia
    • Rest of Asia Pacific 
  • Asia Pacific, by Therapy
  • Asia Pacific, by Indication

Middle East & Africa T-cell therapy Market

  • Middle East & Africa, by Country 
    • UAE
    • Saudi Arabia
    • Qatar
    • South Africa
    • Rest of Middle East & Africa
  • Middle East & Africa, by Therapy,
  • Middle East & Africa, by Indication

South America T-cell therapy Market

  • South America, by Country 
    • Brazil
    • Argentina
    • Colombia
    • Rest of South America
  • South America, by Therapy,
  • South America, by, Indication

Major Companies: Novartis AG; Gilead Sciences; bluebird bio; TCR2 Therapeutics Inc.; Sorrento Therapeutics; and Fate Therapeutics.

Years Covered in the Study:

Historic Year: 2017-2018

Base Year: 2019

Estimated Year: 2020

Forecast Year: 2028

Objectives of this report:

  • To estimate market size for T-cell therapy market on regional and global basis.
  • To identify major segments in T-cell therapy market and evaluate their market shares and demand.
  • To provide a competitive scenario for the T-cell therapy market with major developments observed by key companies in the historic years.
  • To evaluate key factors governing the dynamics of T-cell therapy market with their potential gravity during the forecast period.

Reasons to Buy This Report:

  • Provides niche insights for decision about every possible segment helping in strategic decision making process.
  • Market size estimation of the T-cell therapy market on a regional and global basis.
  • A unique research design for market size estimation and forecast.
  • Identification of major companies operating in the market with related developments
  • Exhaustive scope to cover all the possible segments helping every stakeholder in the T-cell therapy

Customization:

This study is customized to meet your specific requirements:

  • By Segment
  • By Sub-segment
  • By Region/Country
  • Product Specific Competitive Analysis

For more information, contact: sales@quincemarketinsights.com